Skip to content

Research Council of Norway

IICS4all: Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations

€1.3M| Deadline: 14 January 2027 (in 56 days)

Full proposal deadline 14 June 2027

Last seen in a scan/import: .

Catalog updated: .

These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.

Closes 14 Jan 2027. Add it to your calendar, then see what else you're eligible for. Check my fit for this call →

IICS4all, funded through the Research Council of Norway under the ERA4Health partnership, supports investigator-initiated phase III randomised controlled clinical studies in cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases, including studies covering underrepresented populations. The Norwegian allocation is €1.3M, provided jointly with the Regional Health Authorities, and applies to multi-national consortia submitting pragmatic, interventional trial proposals. The call runs as a two-stage process, with a pre-proposal ahead of the full proposal submission.

Details

Funder Research Council of Norway
Budget €1.3M
Deadline 14 January 2027
Consortium Required — transnational multi-national clinical study consortium
Application 2-stage: pre-proposal (14 January 2027) → full proposal (14 June 2027)
TRL 3-6
Eligible countries NO

Eligibility & scope

Joint announcement with Regional Health Authorities for transnational investigator-initiated clinical trials; supports pragmatic phase III randomised controlled multi-national clinical studies, including underrepresented populations.

Who Should Apply

  • •Investigators leading pragmatic phase III randomised controlled trials
  • •Researchers based at Norwegian institutions participating in a multi-national consortium
  • •Studies in cardiovascular, autoimmune, metabolic or non-communicable respiratory disease
  • •Projects designed to include underrepresented populations
  • •Clinical teams with trial-ready interventions at TRL 6-7

Key Dates

  • •Pre-proposal deadline 14 January 2027, full proposal deadline 14 June 2027
  • •Two-stage process: pre-proposal then full proposal
  • •Norwegian funding stream delivered jointly with the Regional Health Authorities

Tips for Applicants

  • ✓Confirm the multi-national consortium structure required under ERA4Health before the pre-proposal stage, since this is a joint call across partner countries.
  • ✓Frame the study as pragmatic and phase III with clear interventional design, the call specifically excludes earlier-phase or purely observational work.
  • ✓Address the underrepresented populations scope explicitly in the proposal, as it is named as a distinct focus of the call.

Frequently Asked Questions

How much funding is available for IICS4all in Norway?

The Norwegian allocation is €1.3M, provided jointly by the Research Council of Norway and the Regional Health Authorities.

What is the deadline for IICS4all?

The pre-proposal deadline is 14 January 2027, followed by a full proposal deadline of 14 June 2027.

Is a consortium required for IICS4all?

Yes, a multi-national consortium is required as part of the ERA4Health partnership.

What diseases does IICS4all cover?

The call funds studies in cardiovascular, autoimmune, metabolic and non-communicable respiratory diseases, including those involving underrepresented populations.

What type of clinical studies does IICS4all fund?

It funds pragmatic, phase III, randomised controlled, multi-national interventional investigator-initiated clinical studies.

cardiovascular-diseaseautoimmune-diseasemetabolic-diseaserespiratory-diseaseclinical-trialsera4healthnorwayconsortium-required
View full call →

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Could IICS4all: Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →